Position in TYRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,674,843
-$2,811,709 QoQ
Shares Held
177,672
-19.8% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 169 holders
Holding Since
Sep 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Derivatives in TYRA
reported options exposure · as of Jun 30, 2026CallValue
$798,500
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. TYRA ranks #159 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in TYRA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $798,500 | 25,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $5,674,843 | 177,672 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,486,552 | 221,581 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $1,532,000 | 40,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $3,007,260 | 114,388 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,014,783 | 144,016 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,899,430 | 407,464 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,758,734 | 404,165 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,380,459 | 315,141 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $246,949 | 10,504 | Shares | Sole | 2024-11-14 | |
| 2023-06-30 | $367,694 | 21,591 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $216,543 | 13,475 | Shares | Sole | 2023-05-15 | |
| 2021-12-31 | $1,540,988 | 109,523 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,644,682 | 93,501 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||